Literature DB >> 22659362

Identification of the Ah-receptor structural determinants for ligand preferences.

Yongna Xing1, Manabu Nukaya, Kenneth A Satyshur, Li Jiang, Vitali Stanevich, Elif Nihal Korkmaz, Lisa Burdette, Gregory D Kennedy, Qiang Cui, Christopher A Bradfield.   

Abstract

The aryl hydrocarbon receptor (AHR) is a transcription factor that responds to diverse ligands and plays a critical role in toxicology, immune function, and cardiovascular physiology. The structural basis of the AHR for ligand promiscuity and preferences is critical for understanding AHR function. Based on the structure of a closely related protein HIF2α, we modeled the AHR ligand binding domain (LBD) bound to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and benzo(a)pyrene (BaP) and identified residues that control ligand preferences by shape and H-bond potential. Mutations to these residues, particularly Q377 and G298, resulted in robust and opposite changes in the potency of TCDD and BaP and up to a 20-fold change in the ratio of TCDD/BaP efficacy. The model also revealed a flexible "belt" structure; molecular dynamic (MD) simulation suggested that the "belt" and several other structural elements in the AHR-LBD are more flexible than HIF2α and likely contribute to ligand promiscuity. Molecular docking of TCDD congeners to a model of human AHR-LBD ranks their binding affinity similar to experimental ranking of their toxicity. Our study reveals key structural basis for prediction of toxicity and understanding the AHR signaling through diverse ligands.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22659362      PMCID: PMC3491955          DOI: 10.1093/toxsci/kfs194

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  43 in total

1.  Evidence that the co-chaperone p23 regulates ligand responsiveness of the dioxin (Aryl hydrocarbon) receptor.

Authors:  A Kazlauskas; L Poellinger; I Pongratz
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

2.  Identification of optimum computational protocols for modeling the aryl hydrocarbon receptor (AHR) and its interaction with ligands.

Authors:  Ashutosh S Jogalekar; Stephan Reiling; Roy J Vaz
Journal:  Bioorg Med Chem Lett       Date:  2010-09-15       Impact factor: 2.823

3.  Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation.

Authors:  Ying Li; Silvia Innocentin; David R Withers; Natalie A Roberts; Alec R Gallagher; Elena F Grigorieva; Christoph Wilhelm; Marc Veldhoen
Journal:  Cell       Date:  2011-10-13       Impact factor: 41.582

4.  Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands.

Authors:  William H Bisson; Daniel C Koch; Edmond F O'Donnell; Sammy M Khalil; Nancy I Kerkvliet; Robert L Tanguay; Ruben Abagyan; Siva Kumar Kolluri
Journal:  J Med Chem       Date:  2009-09-24       Impact factor: 7.446

5.  In vitro analysis of Ah receptor domains involved in ligand-activated DNA recognition.

Authors:  K M Dolwick; H I Swanson; C A Bradfield
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

6.  3D QSAR studies of dioxins and dioxin-like compounds using CoMFA and CoMSIA.

Authors:  Ali Ashek; Cheolju Lee; Hyunsung Park; Seung Joo Cho
Journal:  Chemosphere       Date:  2006-02-17       Impact factor: 7.086

7.  Hepatic transcriptional networks induced by exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  Kevin R Hayes; Gina M Zastrow; Manabu Nukaya; Kalyan Pande; Ed Glover; John P Maufort; Adam L Liss; Yan Liu; Susan M Moran; Aaron L Vollrath; Christopher A Bradfield
Journal:  Chem Res Toxicol       Date:  2007-10-20       Impact factor: 3.739

8.  Artificial ligand binding within the HIF2alpha PAS-B domain of the HIF2 transcription factor.

Authors:  Thomas H Scheuermann; Diana R Tomchick; Mischa Machius; Yan Guo; Richard K Bruick; Kevin H Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-07       Impact factor: 11.205

Review 9.  The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems.

Authors:  Brian J McMillan; Christopher A Bradfield
Journal:  Mol Pharmacol       Date:  2007-05-29       Impact factor: 4.436

10.  Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor.

Authors:  H Reyes; S Reisz-Porszasz; O Hankinson
Journal:  Science       Date:  1992-05-22       Impact factor: 47.728

View more
  25 in total

Review 1.  Ah receptor ligands and their impacts on gut resilience: structure-activity effects.

Authors:  Stephen Safe; Arul Jayaraman; Robert S Chapkin
Journal:  Crit Rev Toxicol       Date:  2020-06-29       Impact factor: 5.635

2.  In silico identification of an aryl hydrocarbon receptor antagonist with biological activity in vitro and in vivo.

Authors:  Ashley J Parks; Michael P Pollastri; Mark E Hahn; Elizabeth A Stanford; Olga Novikov; Diana G Franks; Sarah E Haigh; Supraja Narasimhan; Trent D Ashton; Timothy G Hopper; Dmytro Kozakov; Dimitri Beglov; Sandor Vajda; Jennifer J Schlezinger; David H Sherr
Journal:  Mol Pharmacol       Date:  2014-08-26       Impact factor: 4.436

3.  The aryl hydrocarbon receptor is a tumor suppressor-like gene in glioblastoma.

Authors:  Un-Ho Jin; Keshav Karki; Yating Cheng; Sharon K Michelhaugh; Sandeep Mittal; Stephen Safe
Journal:  J Biol Chem       Date:  2019-06-06       Impact factor: 5.157

4.  Binding studies using Pichia pastoris expressed human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins.

Authors:  Yujuan Zheng; Jinghang Xie; Xin Huang; Jin Dong; Miki S Park; William K Chan
Journal:  Protein Expr Purif       Date:  2016-02-23       Impact factor: 1.650

5.  Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR).

Authors:  Seung-Hyeon Seok; Zhi-Xiong Ma; John B Feltenberger; Hongbo Chen; Hui Chen; Cameron Scarlett; Ziqing Lin; Kenneth A Satyshur; Marissa Cortopassi; Colin R Jefcoate; Ying Ge; Weiping Tang; Christopher A Bradfield; Yongna Xing
Journal:  J Biol Chem       Date:  2017-12-26       Impact factor: 5.157

6.  Analysis of the AHR gene proximal promoter GGGGC-repeat polymorphism in lung, breast, and colon cancer.

Authors:  Barbara C Spink; Michael S Bloom; Susan Wu; Stewart Sell; Erasmus Schneider; Xinxin Ding; David C Spink
Journal:  Toxicol Appl Pharmacol       Date:  2014-11-04       Impact factor: 4.219

7.  Editor's Highlight: Microbial-Derived 1,4-Dihydroxy-2-naphthoic Acid and Related Compounds as Aryl Hydrocarbon Receptor Agonists/Antagonists: Structure-Activity Relationships and Receptor Modeling.

Authors:  Yating Cheng; Un-Ho Jin; Laurie A Davidson; Robert S Chapkin; Arul Jayaraman; Phanourios Tamamis; Asuka Orr; Clint Allred; Michael S Denison; Anatoly Soshilov; Evelyn Weaver; Stephen Safe
Journal:  Toxicol Sci       Date:  2016-11-11       Impact factor: 4.849

8.  Comparative analysis of homology models of the AH receptor ligand binding domain: verification of structure-function predictions by site-directed mutagenesis of a nonfunctional receptor.

Authors:  Domenico Fraccalvieri; Anatoly A Soshilov; Sibel I Karchner; Diana G Franks; Alessandro Pandini; Laura Bonati; Mark E Hahn; Michael S Denison
Journal:  Biochemistry       Date:  2013-01-14       Impact factor: 3.162

9.  Specific ligand binding domain residues confer low dioxin responsiveness to AHR1β of Xenopus laevis.

Authors:  Camila Odio; Sarah A Holzman; Michael S Denison; Domenico Fraccalvieri; Laura Bonati; Diana G Franks; Mark E Hahn; Wade H Powell
Journal:  Biochemistry       Date:  2013-02-27       Impact factor: 3.162

10.  Structure-Dependent Modulation of Aryl Hydrocarbon Receptor-Mediated Activities by Flavonoids.

Authors:  Un-Ho Jin; Hyejin Park; Xi Li; Laurie A Davidson; Clinton Allred; Bhimanagouda Patil; Guddadarangavva Jayaprakasha; Asuka A Orr; Leevin Mao; Robert S Chapkin; Arul Jayaraman; Phanourios Tamamis; Stephen Safe
Journal:  Toxicol Sci       Date:  2018-07-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.